Detalhe da pesquisa
1.
Long-term treatment with lasmiditan in patients with migraine: post hoc analysis of treatment patterns and outcomes from the open-label extension of the CENTURION randomized trial.
J Headache Pain;
25(1): 43, 2024 Mar 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38528476
2.
Long-term treatment with lasmiditan in patients with migraine: Results from the open-label extension of the CENTURION randomized trial.
Cephalalgia;
43(4): 3331024231161745, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36950929
3.
Efficacy of lasmiditan for the acute treatment of perimenstrual migraine.
Cephalalgia;
42(14): 1467-1475, 2022 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35979677
4.
Phase 2 randomized placebo-controlled study of lasmiditan for the acute treatment of migraine in Japanese patients.
Headache;
61(5): 755-765, 2021 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33990951
5.
Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans.
Cephalalgia;
40(1): 19-27, 2020 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31744319
6.
Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme.
BMC Neurol;
20(1): 274, 2020 Jul 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32641075
7.
Evaluation of 2-Hour Post-Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult-to-Treat Migraine Attacks.
Headache;
60(8): 1601-1615, 2020 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32634275
8.
CSF inflammatory biomarkers responsive to treatment in progressive multiple sclerosis capture residual inflammation associated with axonal damage.
Mult Scler;
25(7): 937-946, 2019 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29775134
9.
Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: a comprehensive review of the literature.
J Headache Pain;
20(1): 111, 2019 Dec 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31805851
10.
Molecular-based diagnosis of multiple sclerosis and its progressive stage.
Ann Neurol;
82(5): 795-812, 2017 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29059494
11.
Spinal Arachnoiditis as a Complication of Cryptococcal Meningoencephalitis in Non-HIV Previously Healthy Adults.
Clin Infect Dis;
64(3): 275-283, 2017 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28011613
12.
Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis.
PLoS Pathog;
11(5): e1004884, 2015 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26020932
13.
Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.
Ann Neurol;
78(1): 3-20, 2015 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25808056
14.
Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study.
Neurol Ther;
13(3): 697-714, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38581615
15.
Impact of Migraine on Daily Life: Results of the Observational survey of the Epidemiology, Treatment, and Care of Migraine (OVERCOME [Japan]) Study.
Neurol Ther;
13(1): 165-182, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38175489
16.
Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.
Ann Neurol;
71(5): 614-23, 2012 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22522477
17.
The mechanisms of insulin secretion and calcium signaling in pancreatic ß-cells exposed to fluoroquinolones.
Biol Pharm Bull;
36(1): 31-5, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23302634
18.
Safety profile of lasmiditan in patients with migraine in an Asian population.
Expert Opin Drug Saf;
22(1): 91-101, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35736027
19.
Lasmiditan in Japanese Patients with Common Migraine Comorbidities or Concomitant Medications: A Post Hoc Safety and Efficacy Analysis from the MONONOFU Study.
J Pain Res;
16: 1725-1738, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37255987
20.
Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized Trial.
Neurol Ther;
12(6): 2007-2019, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37698836